Impact of advanced cardiac damage in severe aortic stenosis on short-term and mid-term mortality and rehospitalisation after transcatheter aortic valve implantation: a systematic review and meta-analysis
Open Access
Abstract
Background Severe aortic stenosis (AS) is commonly associated with advanced cardiac damage, including right ventricular dysfunction (RVD), pulmonary hypertension (PH) and tricuspid regurgitation (TR), which may worsen prognosis after transcatheter aortic valve implantation (TAVI). This systematic review and meta-analysis aimed to assess the effect of these conditions on short-term and mid-term mortality and rehospitalisation following TAVI. Methods We conducted a systematic search of PubMed, Scopus and Web of Science for studies published up to June 2025. Eligible studies included adults with AS undergoing TAVI and reported outcomes at 1 month, 6 months or 12 months stratified by the presence of RVD, PH or TR. Studies had to report either HRs, risk ratios (RRs) or sufficient raw event data for mortality or rehospitalisation. Data were synthesised using a random-effects meta-analysis. Subgroup analyses were conducted by cardiac damage severity according to the Généreux staging system and stratified by valve type and diagnostic modality. Risk of bias in included studies was assessed using the Joanna Briggs Institute’s checklist for cohort studies. Meta-regression was performed to explore sources of between-study heterogeneity. Results A total of 34 studies including 26 076 patients met inclusion criteria. Twelve-month HRs for all-cause mortality increased with advancing cardiac damage: borderline stage HR 1.61 (1.22–2.12), stage 3 HR 2.06 (1.63–2.60) and stage 4 HR 2.77 (2.11–3.64). RRs followed a similar trend. Cardiovascular mortality was highest in stage 4 (HR 3.13 (1.20–8.17); RR 2.63 (1.54–4.47)). Rehospitalisation data were limited but suggested elevated risk in stage 3 (RR 1.33 (1.12–1.58)). Meta-regression indicated that age, sex and comorbidities contributed to between-study heterogeneity, particularly in stage 3 analyses. Conclusion Extravalvular cardiac damage, especially RVD (stage 4), is strongly associated with increased short-term and mid-term mortality and rehospitalisation after TAVI. Even borderline-stage patients face elevated risk, underscoring the continuous nature of AS-related cardiac injury. Incorporating cardiac damage staging into preprocedural assessment can enhance risk stratification and guide management to improve patient outcomes. PROSPERO registration number CRD420250638838.Keywords
This publication has 41 references indexed in Scilit:
- Impact of moderate or severe mitral and tricuspid valves regurgitation after transcatheter aortic valve replacementAmerican Heart Journal, 2024
- Complications in transcatheter aortic valve replacement: A comprehensive analysis and management strategiesCurrent Problems in Cardiology, 2024
- Prognostic Implication of Pulmonary Hypertension in Low-Flow Low-Gradient Aortic Stenosis After Transcatheter Aortic Valve ReplacementThe American Journal of Cardiology, 2023
- Features and outcomes of bailout repeat transcatheter aortic valve implantation (TAVI): the Bailout Acute TAVI-in-TAVI to Lessen Events (BATTLE) international registryClinical Research in Cardiology, 2023
- Incidence, Predictive Factors, and Prognostic Impact of Right Ventricular Dysfunction Before Transcatheter Aortic Valve ImplantationThe American Journal of Cardiology, 2021
- Effects of COPD on in‐hospital outcomes of transcatheter aortic valve implantation: Results from the National Inpatient Sample databaseClinical Cardiology, 2020
- Right ventricular systolic function in patients undergoing transcatheter aortic valve implantation: A systematic review and meta-analysisInternational Journal of Cardiology, 2018
- Prevalence and Impact of Pulmonary Hypertension on Patients With Aortic Stenosis Who Underwent Transcatheter Aortic Valve ReplacementThe American Journal of Cardiology, 2015
- Impact of transcatheter aortic valve implantation (TAVI) on pulmonary hyper-tension and clinical outcome in patients with severe aortic valvular stenosisClinical Research in Cardiology, 2014
- Prognostic Impact of Pulmonary Artery Systolic Pressure in Patients Undergoing Transcatheter Aortic Valve Replacement for Aortic StenosisThe American Journal of Cardiology, 2014